Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

BGNE

BeiGene (BGNE)

BeiGene Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BGNE
DateTimeSourceHeadlineSymbolCompany
07/23/20243:10PMBusiness WireBeiGene設立美國旗艦生物製劑生產和臨床研發機構,繼續全球擴張,為全球更多病患提供藥品NASDAQ:BGNEBeiGene Ltd
07/23/20243:10PMBusiness Wireベイジーン、米国に生物製剤製造および臨床研究開発の旗艦施設を開設し、世界のより多くの患者に医薬品を届けるためのグローバルな拡大を継続NASDAQ:BGNEBeiGene Ltd
07/23/20241:56PMBusiness WireBeiGene inaugure un site phare de fabrication de produits biologiques et de R&D clinique aux États-Unis. La société poursuit également son expansion mondiale afin de proposer des médicaments à un plus grand nombre de patients dans le monde entier.NASDAQ:BGNEBeiGene Ltd
07/23/20241:56PMBusiness WireBeiGene eröffnet Flaggschiff-Anlage für Biologika-Herstellung und klinische Forschung und Entwicklung in den USA und setzt die globale Expansion fort, um mehr Patienten auf der ganzen Welt mit Medikamenten zu versorgenNASDAQ:BGNEBeiGene Ltd
07/23/20247:00AMBusiness WireBeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the WorldNASDAQ:BGNEBeiGene Ltd
07/18/202412:32PMBusiness Wireベイジーン、アーロン・ローゼンバーグ氏を最高財務責任者に任命NASDAQ:BGNEBeiGene Ltd
07/18/202410:16AMBusiness WireBeiGene annonce la nomination d'Aaron Rosenberg au poste de Chief Financial OfficerNASDAQ:BGNEBeiGene Ltd
07/18/20249:28AMBusiness WireBeiGene宣布任命Aaron Rosenberg為財務長NASDAQ:BGNEBeiGene Ltd
07/18/20249:28AMBusiness WireBeiGene gibt die Ernennung von Aaron Rosenberg zum Finanzvorstand bekanntNASDAQ:BGNEBeiGene Ltd
07/18/20246:30AMBusiness WireBeiGene Announces Appointment of Aaron Rosenberg as Chief Financial OfficerNASDAQ:BGNEBeiGene Ltd
06/15/202412:05PMBusiness WireBeiGene présentera à l’EHA2024 de nouvelles données sur l’étude SEQUOIA évaluant la bithérapie BRUKINSA® plus vénétoclax dans le traitement de première intention de patients atteints de LLC/PLL à haut risqueNASDAQ:BGNEBeiGene Ltd
06/15/20249:42AMBusiness WireEHA2024: BeiGene präsentiert neue Daten der SEQUOIA-Studie zu BRUKINSA® plus Venetoclax für die Erstlinienbehandlung von Hochrisiko-CLL/SLLNASDAQ:BGNEBeiGene Ltd
06/14/20246:00AMBusiness WireBeiGene to Present New Data from SEQUOIA Study Evaluating BRUKINSA® plus Venetoclax in High-Risk First-Line CLL/SLL at EHA2024NASDAQ:BGNEBeiGene Ltd
06/13/20247:41PMBusiness WireBeiGene and NewBridge Pharmaceuticals FZ LLC Mutually Agree to Conclude BRUKINSA® (Zanubrutinib) Partnership in the Middle East and Africa (MENA) RegionNASDAQ:BGNEBeiGene Ltd
06/07/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
06/07/20245:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
06/07/20245:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
06/07/20245:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
06/07/20245:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
06/07/20244:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
06/07/20244:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
06/07/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
06/07/20244:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
06/07/20244:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
06/07/20244:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
06/05/20245:23PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BGNEBeiGene Ltd
06/05/20244:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGNEBeiGene Ltd
06/04/20246:01AMBusiness WireBeiGene to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:BGNEBeiGene Ltd
05/28/20248:00AMGlobeNewswire Inc.BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human StudyNASDAQ:BGNEBeiGene Ltd
05/24/20246:00AMBusiness WireBRUKINSA® Data at ASCO Underscore Differentiated Clinical Profile for Treatment of CLL and SLLNASDAQ:BGNEBeiGene Ltd
 Showing the most relevant articles for your search:NASDAQ:BGNE

Your Recent History

Delayed Upgrade Clock